Recruiting Lymphoma Studies in Zion
A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). This study will assess how safe and effective epcoritamab plus lena...
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas....
About Lymphoma Clinical Trials in Zion
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Zion, IL. These studies are seeking a combined 409 participants. Research is being sponsored by Genmab, VIVUS LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Zion — FAQ
Are there lymphoma clinical trials in Zion?
Yes, there are 2 lymphoma clinical trials currently recruiting in Zion, IL. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Zion?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Zion research site will contact you about next steps.
Are clinical trials in Zion free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Zion studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Zion are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov